Loading…
Vanta Bioscience (BSE 540729)₹21.99−1.87%Healthcare Research, Analytics & Technology
At the end of the Mar 2026 quarter, Vanta Bioscience's shareholders were: promoters 72.80%, public 27.20%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 425 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Promoters | 69.35% | 69.35% | 69.35% | 69.35% | 72.80% | 72.80% | 72.80% |
| Public | 30.65% | 30.65% | 30.65% | 30.65% | 27.20% | 27.20% | 27.20% |
| Promoter shares pledged | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 387 | 417 | 423 | 407 | 407 | 418 | 425 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Mohan Krishna Mulakala | Promoter | 48.95% | — |
| Dopesh Raja Mulakala | Promoter | 12.10% | — |
| S Chandra Sekhar Rao | Promoter | 7.36% | — |
| Soumya Simhadri | Promoter | 1.28% | — |
| Shravan Chintapatla | Promoter | 1.12% | — |
| Mulakala Karishma | Promoter | 0.70% | — |
| Vyasmurti Madhavrao Shingatgeri | Promoter | 0.70% | — |
| Pradeep Chowdary Veeramachineni | Promoter | 0.30% | — |
| M Sajan Kiran | Promoter | 0.28% | — |
Promoters held 72.80% of Vanta Bioscience at the end of the Mar 2026 quarter, up 3.45 percentage points from 69.35% a year earlier.
No. The Mar 2026 filing shows no pledged promoter shares.
Vanta Bioscience had 425 shareholders at the end of the Mar 2026 quarter, against 423 a year earlier.